223 related articles for article (PubMed ID: 33968746)
1. Effect of Pelvic Bone Marrow Sparing Intensity Modulated Radiation Therapy on Acute Hematologic Toxicity in Rectal Cancer Patients Undergoing Chemo-Radiotherapy.
Huang W; Dang J; Li Y; Cui HX; Lu WL; Jiang QF
Front Oncol; 2021; 11():646211. PubMed ID: 33968746
[TBL] [Abstract][Full Text] [Related]
2. Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?
Wan J; Liu K; Li K; Li G; Zhang Z
Radiat Oncol; 2015 Aug; 10():162. PubMed ID: 26238572
[TBL] [Abstract][Full Text] [Related]
3. Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: a single-center prospective randomized controlled trial.
Huang J; Gu F; Ji T; Zhao J; Li G
Radiat Oncol; 2020 Jul; 15(1):180. PubMed ID: 32727497
[TBL] [Abstract][Full Text] [Related]
4. A dosimetric analysis of tomotherapy based intensity modulated radiation therapy with and without bone marrow sparing in gynecologic malignancies.
Platta CS; Bayliss A; McHaffie D; Tome WA; Straub MR; Bradley KA
Technol Cancer Res Treat; 2013 Feb; 12(1):19-29. PubMed ID: 22974331
[TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis of VMAT and IMRT Techniques: Evaluation of Dose Constraints and Bone Marrow Sparing in Cervical Cancer Patients Undergoing Chemoradiotherapy.
Thakur N; Kaur H; Kaur S; Lehal P; Sudan M; Jain N; Sharma R; Sharma A
Asian Pac J Cancer Prev; 2024 Jan; 25(1):139-144. PubMed ID: 38285777
[TBL] [Abstract][Full Text] [Related]
6. Incorporating
Franco P; Fiandra C; Arcadipane F; Trino E; Giglioli FR; Ragona R; Ricardi U
BMC Cancer; 2017 Nov; 17(1):710. PubMed ID: 29096619
[TBL] [Abstract][Full Text] [Related]
7. Acute hematological toxicity during post-operative bowel sparing image-guided intensity modulated radiation with concurrent cisplatin.
Lewis S; Chopra S; Naga P; Pant S; Dandpani E; Bharadwaj N; Mahantshetty U; Engineer R; Swamidas J; Ghosh J; Gupta S; Shrivastava S
Br J Radiol; 2018 Dec; 91(1092):20180005. PubMed ID: 30179056
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparison study between intensity modulated radiation therapy and three-dimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer.
Song WY; Huh SN; Liang Y; White G; Nichols RC; Watkins WT; Mundt AJ; Mell LK
J Appl Clin Med Phys; 2010 Aug; 11(4):3255. PubMed ID: 21081882
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer.
Mell LK; Tiryaki H; Ahn KH; Mundt AJ; Roeske JC; Aydogan B
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1504-10. PubMed ID: 18640499
[TBL] [Abstract][Full Text] [Related]
10. Association between bone marrow dosimetric parameters and acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy: comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy.
Hui B; Zhang Y; Shi F; Wang J; Wang T; Wang J; Yuan W; Li Y; Liu Z
Int J Gynecol Cancer; 2014 Nov; 24(9):1648-52. PubMed ID: 25275663
[TBL] [Abstract][Full Text] [Related]
11. Tomotherapy as a neoadjuvant treatment for locally advanced esophageal cancer might increase bone marrow toxicity in comparison with intensity-modulated radiotherapy and volumetric-modulated arc therapy.
Wang Y; Xiao Q; Zeng B; Ni Q; Liu X; Liu X; Tian L; Sheng C; Peng L; Wang H
Med Dosim; 2020 Spring; 45(1):e6-e12. PubMed ID: 31176536
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric predictors and Lyman normal tissue complication probability model of hematological toxicity in cervical cancer patients with treated with pelvic irradiation.
Wang D; Yin Y; Zhou Q; Li Z; Ma X; Yin Y; Li B; Bai T; Li D; Zhu J
Med Phys; 2022 Jan; 49(1):756-767. PubMed ID: 34800297
[TBL] [Abstract][Full Text] [Related]
13. Correlations Between Radiation Dose in Bone Marrow and Hematological Toxicity in Patients With Cervical Cancer: A Comparison of 3DCRT, IMRT, and RapidARC.
Chang Y; Yang ZY; Li GL; Li Q; Yang Q; Fan JQ; Zhao YC; Song YQ; Wu G
Int J Gynecol Cancer; 2016 May; 26(4):770-6. PubMed ID: 26844613
[TBL] [Abstract][Full Text] [Related]
14. Association between tumor morphology and dosimetric parameters of organs at risk after intensity-modulated radiotherapy in esophagus cancer.
Li F; Luo Y; Chen J; He L; Liang Y; Lai J; Guo F
J Appl Clin Med Phys; 2022 Jul; 23(7):e13612. PubMed ID: 35635800
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study.
Erpolat OP; Alco G; Caglar HB; Igdem S; Saran A; Dagoglu N; Aslay I; Ozsaran Z; Demirci S; Keven E; Guney Y; Akmansu M; Kilic D; Bayman E; Etiz D; Mandel NM
Eur J Gynaecol Oncol; 2014; 35(1):62-6. PubMed ID: 24654465
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients.
Deng X; Han C; Chen S; Xie C; Yi J; Zhou Y; Zheng X; Deng Z; Jin X
J Appl Clin Med Phys; 2017 Jan; 18(1):25-31. PubMed ID: 28291936
[TBL] [Abstract][Full Text] [Related]
17. Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation.
Kumar T; Schernberg A; Busato F; Laurans M; Fumagalli I; Dumas I; Deutsch E; Haie-Meder C; Chargari C
Cancer Manag Res; 2019; 11():6285-6297. PubMed ID: 31372035
[TBL] [Abstract][Full Text] [Related]
18. Intensity-Modulated Radiotherapy (IMRT) vs Helical Tomotherapy (HT) in Concurrent Chemoradiotherapy (CRT) for Patients with Anal Canal Carcinoma (ACC): an analysis of dose distribution and toxicities.
Yeung R; McConnell Y; Warkentin H; Graham D; Warkentin B; Joseph K; Doll CM
Radiat Oncol; 2015 Apr; 10():92. PubMed ID: 25903798
[TBL] [Abstract][Full Text] [Related]
19. Different functional lung-sparing strategies and radiotherapy techniques for patients with esophageal cancer.
Zhou PX; Wang RH; Yu H; Zhang Y; Zhang GQ; Zhang SX
Front Oncol; 2022; 12():898141. PubMed ID: 36091164
[TBL] [Abstract][Full Text] [Related]
20. Comparison of bone marrow sparing intensity modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3DCRT) in carcinoma of anal canal: a prospective study.
Rattan R; Kapoor R; Bahl A; Gupta R; Oinam AS; Kaur S
Ann Transl Med; 2016 Feb; 4(4):70. PubMed ID: 27004217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]